205 related articles for article (PubMed ID: 38667960)
1.
Ledoux MP; Dicop E; Sabou M; Letscher-Bru V; Castelain V; Danion F; Herbrecht R
J Fungi (Basel); 2024 Apr; 10(4):. PubMed ID: 38667960
[TBL] [Abstract][Full Text] [Related]
2. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Park BJ; Pappas PG; Wannemuehler KA; Alexander BD; Anaissie EJ; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt L; Ito JI; Kauffman CA; Lyon GM; Marr KA; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wingard JR; Walsh TJ; Kontoyiannis DP
Emerg Infect Dis; 2011 Oct; 17(10):1855-64. PubMed ID: 22000355
[TBL] [Abstract][Full Text] [Related]
3. Detection of the 'Big Five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes.
Thornton CR
Adv Appl Microbiol; 2020; 110():1-61. PubMed ID: 32386603
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole in the treatment of invasive mold infections in transplant recipients.
Fortún J; Martín-Dávila P; Sánchez MA; Pintado V; Alvarez ME; Sánchez-Sousa A; Moreno S
Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):408-13. PubMed ID: 12827536
[TBL] [Abstract][Full Text] [Related]
6. All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections.
Hoenigl M; Levitz SM; Schuetz AN; Zhang SX; Cornely OA
mBio; 2021 Feb; 12(1):. PubMed ID: 33622731
[TBL] [Abstract][Full Text] [Related]
7. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
8. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
[TBL] [Abstract][Full Text] [Related]
9. Mold Infections in Solid Organ Transplant Recipients.
Lemonovich TL
Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
[TBL] [Abstract][Full Text] [Related]
10. Changes in the epidemiological landscape of invasive mould infections and disease.
Lass-Flörl C; Cuenca-Estrella M
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
[TBL] [Abstract][Full Text] [Related]
11. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients.
Nucci M
Curr Opin Infect Dis; 2003 Dec; 16(6):607-12. PubMed ID: 14624113
[TBL] [Abstract][Full Text] [Related]
12. Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.
Hardak E; Fuchs E; Geffen Y; Zuckerman T; Oren I
Mycopathologia; 2020 Apr; 185(2):347-355. PubMed ID: 32100219
[TBL] [Abstract][Full Text] [Related]
13. Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; Solé A; Cañada-Martínez A; Muñoz-Núñez CF; Pastor A; Montull B; Falomir-Salcedo P; Valentín A; López-Hontangas JL; Pemán J
Rev Iberoam Micol; 2021; 38(4):184-187. PubMed ID: 34642117
[TBL] [Abstract][Full Text] [Related]
14. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
Jacobs SE; Wengenack NL; Walsh TJ
Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
[TBL] [Abstract][Full Text] [Related]
15. The changing face of invasive fungal infections in hematopoietic cell transplant recipients.
Wingard JR
Curr Opin Oncol; 2005 Mar; 17(2):89-92. PubMed ID: 15725910
[TBL] [Abstract][Full Text] [Related]
16. Emergence of the Molds Other than Aspergillus in Immunocompromised Patients.
Arif S; Perfect JR
Clin Chest Med; 2017 Sep; 38(3):555-573. PubMed ID: 28797495
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.
Gold JAW; Revis A; Thomas S; Perry L; Blakney RA; Chambers T; Bentz ML; Berkow EL; Lockhart SR; Lysen C; Nunnally NS; Jordan A; Kelly HC; Montero AJ; Farley MM; Oliver NT; Pouch SM; Webster AS; Jackson BR; Beer KD
Open Forum Infect Dis; 2022 Jul; 9(7):ofac215. PubMed ID: 35794945
[TBL] [Abstract][Full Text] [Related]
18. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Bhatti Z; Shaukat A; Almyroudis NG; Segal BH
Mycopathologia; 2006 Jul; 162(1):1-15. PubMed ID: 16830186
[TBL] [Abstract][Full Text] [Related]
19. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
20. Update on therapeutic approaches for invasive fungal infections in adults.
Boutin CA; Luong ML
Ther Adv Infect Dis; 2024; 11():20499361231224980. PubMed ID: 38249542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
